Who will benefit from psychedelic medicine? | Curio

Who will benefit from psychedelic medicine?

33 mins | Sep 30, 2020

The troubles of accessibility are already present. MDMA-assisted psychotherapy is a turning point in the mainstreaming of psychedelics. These substances are being touted as a game-changing intervention for mental health. But it’s not clear if their promise will be accessible to all. Whitney Joiner investigates.

publisher logo

From The Washington Post

Read along